Vertex Pharmaceuticals Inc (VRTX) Stock Price, Quote & AI Analysis

Live VRTX stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Vertex Pharmaceuticals Inc.

TradeVae provides AI-driven analysis and real-time market intelligence for Vertex Pharmaceuticals Inc (VRTX), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

VRTX
Vertex Pharmaceuticals Inc
real-time
$0.00 +0.00 (+0.00%)
Open
466.790000
High
473.190000
Low
464.010000
Volume
118,628
VWAP
-
Market Cap
$119,222,478,686.90
52W Range
$362.50 - $519.68
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Feb 12, 2026 Q4
After Hours
EPS Estimate: $5.1852
Revenue Estimate: $3,240,616,989.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Vertex Pharmaceuticals Inc's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Vertex Pharmaceuticals Inc Overview

Company information

Company Overview

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Company Details
Market Cap
$119.45B
Shares Outstanding
253,719,000
Weighted Shares Outstanding
253,718,831
CEO
Reshma Kewalramani
Address
50 NORTHERN AVENUE, BOSTON, MA, 02210
Employees
6,100
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Vertex Pharmaceuticals Inc Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...